View in EDS

75PCemiplimab, a human PD-1 monoclonal antibody, in patients (pts) with recurrent or metastatic cervical cancer: Interim data from phase I cohorts.

Saved in:
Bibliographic Details
Title: 75PCemiplimab, a human PD-1 monoclonal antibody, in patients (pts) with recurrent or metastatic cervical cancer: Interim data from phase I cohorts.
Authors: Rischin, D1 (AUTHOR), Gil-Martin, M2 (AUTHOR), González-Martin, A3 (AUTHOR), Brana, I4 (AUTHOR), Hou, J Y5 (AUTHOR), Cho, D6 (AUTHOR), Falchook, G7 (AUTHOR), Formenti, S8 (AUTHOR), Jabbour, S9 (AUTHOR), Moore, K10 (AUTHOR), Naing, A11 (AUTHOR), Papadopoulos, K P12 (AUTHOR), Baranda, J13 (AUTHOR), Weise, A14 (AUTHOR), Fury, M G15 (AUTHOR), Feng, M16 (AUTHOR), Li, J17 (AUTHOR), Lowy, I15 (AUTHOR), Mathias, M15 (AUTHOR)
Source: Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 133734937
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 75PCemiplimab, a human PD-1 monoclonal antibody, in patients (pts) with recurrent or metastatic cervical cancer: Interim data from phase I cohorts.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Rischin%2C+D%22">Rischin, D</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gil-Martin%2C+M%22">Gil-Martin, M</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22González-Martin%2C+A%22">González-Martin, A</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Brana%2C+I%22">Brana, I</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hou%2C+J+Y%22">Hou, J Y</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cho%2C+D%22">Cho, D</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Falchook%2C+G%22">Falchook, G</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Formenti%2C+S%22">Formenti, S</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jabbour%2C+S%22">Jabbour, S</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Moore%2C+K%22">Moore, K</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Naing%2C+A%22">Naing, A</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Papadopoulos%2C+K+P%22">Papadopoulos, K P</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Baranda%2C+J%22">Baranda, J</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Weise%2C+A%22">Weise, A</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fury%2C+M+G%22">Fury, M G</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Feng%2C+M%22">Feng, M</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+J%22">Li, J</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lowy%2C+I%22">Lowy, I</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mathias%2C+M%22">Mathias, M</searchLink><relatesTo>15</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=133734937
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/annonc/mdy487.006
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: N.PAG
    Titles:
      – TitleFull: 75PCemiplimab, a human PD-1 monoclonal antibody, in patients (pts) with recurrent or metastatic cervical cancer: Interim data from phase I cohorts.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rischin, D
      – PersonEntity:
          Name:
            NameFull: Gil-Martin, M
      – PersonEntity:
          Name:
            NameFull: González-Martin, A
      – PersonEntity:
          Name:
            NameFull: Brana, I
      – PersonEntity:
          Name:
            NameFull: Hou, J Y
      – PersonEntity:
          Name:
            NameFull: Cho, D
      – PersonEntity:
          Name:
            NameFull: Falchook, G
      – PersonEntity:
          Name:
            NameFull: Formenti, S
      – PersonEntity:
          Name:
            NameFull: Jabbour, S
      – PersonEntity:
          Name:
            NameFull: Moore, K
      – PersonEntity:
          Name:
            NameFull: Naing, A
      – PersonEntity:
          Name:
            NameFull: Papadopoulos, K P
      – PersonEntity:
          Name:
            NameFull: Baranda, J
      – PersonEntity:
          Name:
            NameFull: Weise, A
      – PersonEntity:
          Name:
            NameFull: Fury, M G
      – PersonEntity:
          Name:
            NameFull: Feng, M
      – PersonEntity:
          Name:
            NameFull: Li, J
      – PersonEntity:
          Name:
            NameFull: Lowy, I
      – PersonEntity:
          Name:
            NameFull: Mathias, M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 12
              Text: 2018 Supplement
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 29
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1